Healthcare -
Biotechnology - NASDAQ - US
$ 2.02
3.06 %
$ 62.7 M
Market Cap
-1.03
P/E
IMRX - CASH FROM OPERATIONS
Cash from Operations IMRX - Immuneering Corporation
-49 M
LAST VALUE
-25.99%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR